# A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population

> **NCT00534872** · PHASE1 · WITHDRAWN · sponsor: **GlaxoSmithKline**

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** SB-649868

## Key facts

- **NCT ID:** NCT00534872
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-10
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was stoppend before recruitment start for preclinical safety finding in rats.
- **Last updated:** 2015-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00534872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00534872, "A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00534872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*